Back to search

Article

Anti-Carbamylated Protein Antibody Identifies Seronegative Early Rheumatoid Arthritis Missed by Anti-CCP, Independently Predicts Joint Deformity, and Extends ACR/EULAR Classification: A Dose-Response and Bootstrap-Validated Cross-Sectional Study from North India

2026-06-02

Abstract excerpt

<title>Abstract</title> <p>Background Anti-cyclic citrullinated peptide (anti-CCP) antibodies miss 30–50% of early rheumatoid arthritis (RA) presentations, delaying treatment and permitting structural damage. Anti-carbamylated protein (anti-CarP) antibodies target homocitrullinated proteins via an HLA-DRB1 shared-epitope-independent pathway biochemically distinct from anti-CCP, making them candidates to fill thi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0197863c-c722-5bde-b509-4ae3868fc930
DOI
10.21203/rs.3.rs-9782080/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Anti-Carbamylated Protein Antibody Identifies Seronegative Early Rheumatoid Arthritis Missed by Anti-CCP, Independently Predicts Joint Deformity, and Extends ACR/EULAR Classification: A Dose-Response and Bootstrap-Validated Cross-Sectional Study from North IndiaDOI 10.21203/rs.3.rs-9782080/v1
Select a neighboring publication to make it the new centre.